INS and metabolic dysfunction-associated steatotic liver disease: As hepatic insulin signaling positively regulates hepatic DNL, the condition in NAFLD wherein insulin fails to suppress gluconeogenesis but continues to activate DNL is referred to as “selective hepatic insulin resistance” [173].